The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. (October 2017)
- Record Type:
- Journal Article
- Title:
- The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. (October 2017)
- Main Title:
- The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis
- Authors:
- Freeman, Daniel
Sheaves, Bryony
Goodwin, Guy M
Yu, Ly-Mee
Nickless, Alecia
Harrison, Paul J
Emsley, Richard
Luik, Annemarie I
Foster, Russell G
Wadekar, Vanashree
Hinds, Christopher
Gumley, Andrew
Jones, Ray
Lightman, Stafford
Jones, Steve
Bentall, Richard
Kinderman, Peter
Rowse, Georgina
Brugha, Traolach
Blagrove, Mark
Gregory, Alice M
Fleming, Leanne
Walklet, Elaine
Glazebrook, Cris
Davies, E Bethan
Hollis, Chris
Haddock, Gillian
John, Bev
Coulson, Mark
Fowler, David
Pugh, Katherine
Cape, John
Moseley, Peter
Brown, Gary
Hughes, Claire
Obonsawin, Marc
Coker, Sian
Watkins, Edward
Schwannauer, Matthias
MacMahon, Kenneth
Siriwardena, A Niroshan
Espie, Colin A
… (more) - Abstract:
- Summary: Background: Sleep difficulties might be a contributory causal factor in the occurrence of mental health problems. If this is true, improving sleep should benefit psychological health. We aimed to determine whether treating insomnia leads to a reduction in paranoia and hallucinations. Methods: We did this single-blind, randomised controlled trial (OASIS) at 26 UK universities. University students with insomnia were randomly assigned (1:1) with simple randomisation to receive digital cognitive behavioural therapy (CBT) for insomnia or usual care, and the research team were masked to the treatment. Online assessments took place at weeks 0, 3, 10 (end of therapy), and 22. The primary outcome measures were for insomnia, paranoia, and hallucinatory experiences. We did intention-to-treat analyses. The trial is registered with the ISRCTN registry, number ISRCTN61272251. Findings: Between March 5, 2015, and Feb 17, 2016, we randomly assigned 3755 participants to receive digital CBT for insomnia (n=1891) or usual practice (n=1864). Compared with usual practice, the sleep intervention at 10 weeks reduced insomnia (adjusted difference 4·78, 95% CI 4·29 to 5·26, Cohen's d=1·11; p<0·0001), paranoia (−2·22, −2·98 to −1·45, Cohen's d=0·19; p<0·0001), and hallucinations (−1·58, −1·98 to −1·18, Cohen's d=0·24; p<0·0001). Insomnia was a mediator of change in paranoia and hallucinations. No adverse events were reported. Interpretation: To our knowledge, this is the largest randomisedSummary: Background: Sleep difficulties might be a contributory causal factor in the occurrence of mental health problems. If this is true, improving sleep should benefit psychological health. We aimed to determine whether treating insomnia leads to a reduction in paranoia and hallucinations. Methods: We did this single-blind, randomised controlled trial (OASIS) at 26 UK universities. University students with insomnia were randomly assigned (1:1) with simple randomisation to receive digital cognitive behavioural therapy (CBT) for insomnia or usual care, and the research team were masked to the treatment. Online assessments took place at weeks 0, 3, 10 (end of therapy), and 22. The primary outcome measures were for insomnia, paranoia, and hallucinatory experiences. We did intention-to-treat analyses. The trial is registered with the ISRCTN registry, number ISRCTN61272251. Findings: Between March 5, 2015, and Feb 17, 2016, we randomly assigned 3755 participants to receive digital CBT for insomnia (n=1891) or usual practice (n=1864). Compared with usual practice, the sleep intervention at 10 weeks reduced insomnia (adjusted difference 4·78, 95% CI 4·29 to 5·26, Cohen's d=1·11; p<0·0001), paranoia (−2·22, −2·98 to −1·45, Cohen's d=0·19; p<0·0001), and hallucinations (−1·58, −1·98 to −1·18, Cohen's d=0·24; p<0·0001). Insomnia was a mediator of change in paranoia and hallucinations. No adverse events were reported. Interpretation: To our knowledge, this is the largest randomised controlled trial of a psychological intervention for a mental health problem. It provides strong evidence that insomnia is a causal factor in the occurrence of psychotic experiences and other mental health problems. Whether the results generalise beyond a student population requires testing. The treatment of disrupted sleep might require a higher priority in mental health provision. Funding: Wellcome Trust. … (more)
- Is Part Of:
- Lancet. Volume 4:Number 10(2017)
- Journal:
- Lancet
- Issue:
- Volume 4:Number 10(2017)
- Issue Display:
- Volume 4, Issue 10 (2017)
- Year:
- 2017
- Volume:
- 4
- Issue:
- 10
- Issue Sort Value:
- 2017-0004-0010-0000
- Page Start:
- 749
- Page End:
- 758
- Publication Date:
- 2017-10
- Subjects:
- Psychiatry -- Periodicals
616.89 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22150366 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/S2215-0366(17)30328-0 ↗
- Languages:
- English
- ISSNs:
- 2215-0366
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.092000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4704.xml